Cargando…
Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion
OBJECTIVE: When considering repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder, clinicians often face a lack of detailed information on potential interactions between rTMS and pharmacotherapy. This is particularly relevant to patients receiving bupropion, a commonly pr...
Autores principales: | Dobek, Christine E, Blumberger, Daniel M, Downar, Jonathan, Daskalakis, Zafiris J, Vila-Rodriguez, Fidel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670017/ https://www.ncbi.nlm.nih.gov/pubmed/26664122 http://dx.doi.org/10.2147/NDT.S91126 |
Ejemplares similares
-
Differential symptom cluster responses to repetitive transcranial magnetic stimulation treatment in depression
por: Kaster, Tyler S., et al.
Publicado: (2022) -
The role of low-frequency repetitive transcranial magnetic stimulation in major depression: A call to increase the evidence base
por: Miron, Jean-Philippe, et al.
Publicado: (2020) -
Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis
por: Mendlowitz, Andrew B., et al.
Publicado: (2019) -
Predictors of remission after repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: An analysis from the randomised non-inferiority THREE-D trial
por: Trevizol, Alisson P., et al.
Publicado: (2020) -
Non-linear Entropy Analysis in EEG to Predict Treatment Response to Repetitive Transcranial Magnetic Stimulation in Depression
por: Shalbaf, Reza, et al.
Publicado: (2018)